98%
921
2 minutes
20
Aims: To evaluate the potential association of anemia with micro- and macrovascular complications in Chinese patient with type 2 diabetes mellitus (T2DM).
Methods: A total of 1997 patients with T2DM were included in this cross-sectional study. Patients were defined as anemic, if hemoglobin (Hb) levels were < 13 g/dL in males and < 12 g/dL in females. Data on demographics, anthropometric parameters, and co-morbidities were extracted for each patient.
Results: Twenty two percent of T2DM patients (439/1997) had anemia, and those patients with higher rates of micro- and macrovascular complications had higher rates of anemia. Univariate logistic regression analysis showed that anemia was a risk factor of microvascular complications (OR = 1.83, 95% CI: 1.45 - 2.31; P < 0.001) and macrovascular complications (OR = 2.10, 95% CI: 1.63 - 2.71; P < 0.001). After adjusting for conventional risk factors, anemia remained positively associated with microvascular complications (OR = 1.52, 95% CI: 1.17 - 1.99), but lost its association with macrovascular complications (OR = 1.01, 95% CI: 0.73 - 1.41). Anemia was also independently associated with diabetic retinopathy, nephropathy, and peripheral neuropathy.
Conclusions: These findings suggest that anemia was related to both micro- and macrovascular complications in Chinese patients with T2DM, but was only an independent risk factor of microvascular complications. Assessment of Hb levels in T2DM patients may help to prevent subsequent diabetic micro- and macrovascular complications.
Download full-text PDF |
Source |
---|
Medicine (Baltimore)
September 2025
Al Mouwasat University Hospital, Damascus University, Damascus, Syria.
Rationale: Systemic sclerosis (SS) is an immune-mediated connective disease characterized by skin fibrosis, microvascular damage, and multisystem manifestations. One of the most important processes in connective tissue disorders is vasculitis. The clinical findings can differ when the disease is presented with an antineutrophil cytoplasmic antibody.
View Article and Find Full Text PDFCureus
August 2025
General Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, GBR.
Diabetes mellitus is a metabolic condition leading to elevated blood glucose levels due to insulin deficiency, insulin resistance, or a combination of both. Chronically raised blood glucose levels can lead to a broad variety of microvascular and macrovascular complications. Neurological disorders are a common manifestation of diabetes mellitus, and poorly controlled diabetes mellitus frequently causes peripheral sensorimotor polyneuropathy and autonomic neuropathy.
View Article and Find Full Text PDFKorean J Physiol Pharmacol
September 2025
Department of Physiology & Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Diabetes mellitus is a major global health concern associated with micro-and macrovascular complications. Among the diverse mechanisms that contribute to vascular dysfunction in diabetes, endothelial to mesenchymal transition (EndMT) has emerged as a key pathological process. EndMT involves the loss of endothelial cell characteristics and the acquisition of mesenchymal features, resulting in impaired endothelial function, increased fibrosis, and inflammation.
View Article and Find Full Text PDFPhytother Res
September 2025
Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.
Macrovascular complications of diabetes mellitus (DM) are diseases of the peripheral and coronary arteries and the cerebrovascular system. Despite the availability of several conventional antidiabetic drugs, the macrovascular complications associated with DM remain a major health burden, partly because the focus of diabetes management has been glucocentric. Interestingly, phytochemicals, particularly flavonoids and other phenolics, were highly promising in the treatment of diabetes-associated macrovascular complications.
View Article and Find Full Text PDFDiabetes Res Clin Pract
September 2025
Diabetes Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia; Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Victoria, Aus
Aims: To examine 30-year glycemic trajectory in children with early-onset type 1 diabetes (T1D) and ascertain which stages of childhood and adolescence were most contributory to subsequent microvascular disease.
Methods: We recruited children diagnosed with T1D between 1990-1992 into the Cognition and Longitudinal Assessment of Risk Factors over 30 Years cohort study in Australia. HbA was collected from medical records and microvascular complications assessed through self-reports, clinical screenings, retinal photographs, and urinary albumin-creatinine testing.